146 related articles for article (PubMed ID: 17548701)
21. Molecular analysis of the FHIT gene in human prostate cancer.
Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683
[TBL] [Abstract][Full Text] [Related]
22. Lack of association of fragile histidine triad (FHIT) polymorphisms with lung cancer in the Korean population.
Jung HY; Sung JS; Whang YM; Shin HD; Park BL; Kim JS; Shin SW; Seo HY; Sung HJ; Choi IK; Oh SC; Seo JH; Kim YH
J Hum Genet; 2007; 52(8):668. PubMed ID: 17609851
[TBL] [Abstract][Full Text] [Related]
23. ICAM gene cluster SNPs and prostate cancer risk in African Americans.
Chen H; Hernandez W; Shriver MD; Ahaghotu CA; Kittles RA
Hum Genet; 2006 Aug; 120(1):69-76. PubMed ID: 16733712
[TBL] [Abstract][Full Text] [Related]
24. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk.
Salinas CA; Kwon E; Carlson CS; Koopmeiners JS; Feng Z; Karyadi DM; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1203-13. PubMed ID: 18483343
[TBL] [Abstract][Full Text] [Related]
25. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
[TBL] [Abstract][Full Text] [Related]
26. CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.
Stone A; Ratnasinghe LD; Emerson GL; Modali R; Lehman T; Runnells G; Carroll A; Carter W; Barnhart S; Rasheed AA; Greene G; Johnson DE; Ambrosone CB; Kadlubar FF; Lang NP
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1257-61. PubMed ID: 15894682
[TBL] [Abstract][Full Text] [Related]
27. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
[TBL] [Abstract][Full Text] [Related]
28. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract][Full Text] [Related]
30. Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers.
Lee YC; Wu CT; Shih JY; Jou YS; Chang YL
Br J Cancer; 2004 Jun; 90(12):2378-83. PubMed ID: 15150628
[TBL] [Abstract][Full Text] [Related]
31. Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.
Beuten J; Gelfond JA; Franke JL; Shook S; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):588-99. PubMed ID: 20086112
[TBL] [Abstract][Full Text] [Related]
32. EphB2 SNPs and sporadic prostate cancer risk in African American men.
Robbins CM; Hooker S; Kittles RA; Carpten JD
PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
34. Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.
Shook SJ; Beuten J; Torkko KC; Johnson-Pais TL; Troyer DA; Thompson IM; Leach RJ
Clin Cancer Res; 2007 Oct; 13(19):5959-64. PubMed ID: 17908993
[TBL] [Abstract][Full Text] [Related]
35. Fragile histidine triad gene alterations are not essential for hepatocellular carcinoma development in South Korea.
Nam CW; Shin JW; Park NH
World J Gastroenterol; 2008 Jun; 14(22):3526-33. PubMed ID: 18567082
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
37. Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D; Zhou J; Sun Y; Patel NP; Darga LL; Heilbrun LK; Powell IJ; Severson RK; Everson RB
Urol Oncol; 2006; 24(1):21-7. PubMed ID: 16414488
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American men.
Hughes L; Ruth K; Rebbeck TR; Giri VN
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):308-14. PubMed ID: 24061634
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing contributes to frequent loss of the fragile histidine triad tumour suppressor in basal cell carcinomas.
Goldberg M; Rummelt C; Laerm A; Helmbold P; Holbach LM; Ballhausen WG
Br J Dermatol; 2006 Dec; 155(6):1154-8. PubMed ID: 17107382
[TBL] [Abstract][Full Text] [Related]
40. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians.
Nowell S; Ratnasinghe DL; Ambrosone CB; Williams S; Teague-Ross T; Trimble L; Runnels G; Carrol A; Green B; Stone A; Johnson D; Greene G; Kadlubar FF; Lang NP
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):270-6. PubMed ID: 14973106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]